Biden’s State Of The Union Will Mention Drug Prices, But Not Outline Any New Plans
President’s address to Congress expected to urge action on the provisions in the stalled Build Back Better legislation as part of a call to address inflation – though whether the speech will include the “i-word” remains unclear. PhRMA emphasizes that drug prices are stable.
You may also be interested in...
Drug Price Increases Accelerate: ‘Political Opportunism’ In A Return To Business As Usual?
Advocates for drug pricing reform don’t have much in the way of price increases to complain about at the moment – but they argue that the price hikes they are seeing suggest a growing confidence among manufacturers that the threat of drug pricing reform is subsiding.
Biden vs. Pharma: ‘You Come For The King…’
The president’s state of the union address comes after a year of mostly disappointing efforts for the administration on COVID and drug pricing.
Pink Sheet Podcast: Medicare Inflation Rebates And Negotiation, Leqembi Reimbursement, US FDA Gene Therapy Chief
Pink Sheet reporter and editors discuss the first round of mandated Medicare inflation rebates and new guidance on price negotiations, consider the VA’s decision to cover the Alzheimer’s drug Leqembi, and the US FDA continuing to search for a cell and gene therapy office leader.